Treatment of HIV-Infected Individuals with the Histone Deacetylase Inhibitor Panobinostat Results in Increased Numbers of Regulatory T Cells and Limits Ex Vivo Lipopolysaccharide-Induced Inflammatory Responses

Eitemau Tebyg

• Activation of Latent Human Immunodeficiency Virus by the Histone Deacetylase Inhibitor Panobinostat: A Pilot Study to Assess Effects on the Central Nervous System
  gan: Rasmussen, Thomas A., et al.
  Cyhoeddwyd: (2015)
• Innate Immune Activity Correlates with CD4 T Cell-Associated HIV-1 DNA Decline during Latency-Reversing Treatment with Panobinostat
  gan: Olesen, Rikke, et al.
  Cyhoeddwyd: (2015)
• Comparison of HDAC inhibitors in clinical development: Effect on HIV production in latently infected cells and T-cell activation
  gan: Rasmussen, Thomas Aagaard, et al.
  Cyhoeddwyd: (2013)
• The Use of Toll-Like Receptor Agonists in HIV-1 Cure Strategies
  gan: Martinsen, Janne Tegder, et al.
  Cyhoeddwyd: (2020)
• Fimepinostat, a novel dual inhibitor of HDAC and PI3K, effectively reverses HIV-1 latency ex vivo without T cell activation
  gan: Gunst, Jesper D, et al.
  Cyhoeddwyd: (2019)